Long term follow up of bone mineral density in Egyptian Gaucher disease type 3 patients on enzyme replacement therapy

被引：0
|
作者：
Abdelwahab, Magy [1 ]
机构：
[1] Cairo Univ, Pediat Hosp, Cairo, Egypt
来源：
MOLECULAR GENETICS AND METABOLISM | 2025年 / 144卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2024.108628
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1
引用
收藏
页数：2
相关论文
共 50 条
  • [21] LONG-TERM EFFECTS OF ENZYMATIC REPLACEMENT THERAPY IN GAUCHER TYPE 3 DISEASE
    Bertin, N.
    Deroma, L.
    Ciana, G.
    Sechi, A.
    Dardis, A.
    Deganuto, M.
    Malini, E.
    Bembi, B.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S100 - S100
  • [22] Decreased bone density in splenectomized Gaucher patients receiving enzyme replacement therapy
    Schiffmann, R
    Mankin, H
    Dambrosia, JM
    Xavier, RJ
    Kreps, C
    Hill, SC
    Barton, NW
    Rosenthal, DI
    BLOOD CELLS MOLECULES AND DISEASES, 2002, 28 (02) : 288 - 296
  • [23] Response of Gaucher bone disease to enzyme replacement therapy
    Poll, LW
    Maas, M
    Terk, MR
    Roca-Espiau, M
    Bembi, B
    Ciana, G
    Weinreb, NJ
    BRITISH JOURNAL OF RADIOLOGY, 2002, 75 : A25 - A36
  • [24] Investigation of bone mineral density and the changes by enzyme replacement therapy in patients with Fabry disease
    Nose, Yuma
    Fujii, Hideki
    Goto, Shunsuke
    Kono, Keiji
    Okamoto, Hayaki
    Watanabe, Kentaro
    Nishi, Shinichi
    MOLECULAR GENETICS AND METABOLISM, 2023, 139 (04)
  • [25] Enzyme replacement therapy in adult patients with type I Gaucher disease
    Ponomarev, R., V
    Lukina, E. A.
    TERAPEVTICHESKII ARKHIV, 2019, 91 (07) : 127 - 131
  • [26] Enzyme replacement therapy in romanian patients with type 1 Gaucher disease
    Sido, P. Grigorescu
    Drugan, C.
    Cret, V.
    Al-Kzouz, C.
    Denes, C.
    Zimmermann, A.
    Coldea, C.
    CLINICAL THERAPEUTICS, 2007, 29 : S118 - S118
  • [27] A prospective study of enzyme replacement therapy in type 3 Gaucher disease
    Schiffmann, R
    Parker, CC
    Scott, LJC
    DeGraba, T
    Brady, RO
    Barton, NW
    NEUROLOGY, 1996, 46 (02) : 1107 - 1107
  • [28] Bone mineral density and lean muscle mass characteristics in children with Gaucher disease treated with enzyme replacement therapy or untreated
    Dar, Liron
    Tiomkin, Maayan
    Elstein, Deborah
    Zimran, Ari
    Lebel, Ehud
    BLOOD CELLS MOLECULES AND DISEASES, 2018, 68 : 135 - 138
  • [29] The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease - Response
    Charrow, J.
    Dulisse, B.
    Grabowski, G. A.
    Weinreb, N. J.
    CLINICAL GENETICS, 2007, 72 (02) : 161 - 161
  • [30] Alendronate disodium improves bone mineral density in adults receiving enzyme replacement therapy (ERT) for Gaucher disease.
    Wenstrup, RJ
    Bailey, L
    Grabowski, GA
    Guo, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 674 - 674
12345